Cargando…
Direct Oral Anticoagulants versus Warfarin in Octogenarians with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis
Direct oral anticoagulants (DOACs) have been demonstrated to be more effective and safer than vitamin-K antagonist (VKA) for stroke prevention in patients with nonvalvular atrial fibrillation (AF). This meta-analysis aims to assess the effect of DOACS vs. VKA in patients ≥ 80 and AF. Primary endpoin...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618042/ https://www.ncbi.nlm.nih.gov/pubmed/34830548 http://dx.doi.org/10.3390/jcm10225268 |
_version_ | 1784604652531089408 |
---|---|
author | Bonanad, Clara García-Blas, Sergio Torres Llergo, Javier Fernández-Olmo, Rosa Díez-Villanueva, Pablo Ariza-Solé, Albert Martínez-Sellés, Manuel Raposeiras, Sergio Ayesta, Ana Bertomeu-González, Vicente Tarazona Santabalbina, Francisco Facila, Lorenzo Vivas, David Gabaldón-Pérez, Ana Bodi, Vicente Nuñez, Julio Cordero, Alberto |
author_facet | Bonanad, Clara García-Blas, Sergio Torres Llergo, Javier Fernández-Olmo, Rosa Díez-Villanueva, Pablo Ariza-Solé, Albert Martínez-Sellés, Manuel Raposeiras, Sergio Ayesta, Ana Bertomeu-González, Vicente Tarazona Santabalbina, Francisco Facila, Lorenzo Vivas, David Gabaldón-Pérez, Ana Bodi, Vicente Nuñez, Julio Cordero, Alberto |
author_sort | Bonanad, Clara |
collection | PubMed |
description | Direct oral anticoagulants (DOACs) have been demonstrated to be more effective and safer than vitamin-K antagonist (VKA) for stroke prevention in patients with nonvalvular atrial fibrillation (AF). This meta-analysis aims to assess the effect of DOACS vs. VKA in patients ≥ 80 and AF. Primary endpoints were stroke or systemic embolism and all-cause death. Secondary endpoints included major bleeding, intracranial bleeding, and gastrointestinal bleeding. A random-effects model was selected due to significant heterogeneity. A total of 147,067 patients from 16 studies were included, 71,913 (48.90%) treated with DOACs and 75,154 with VKA (51.10%). The stroke rate was significantly lower in DOACs group compared with warfarin group (Relative risk (RR): 0.72; 95% confidence interval (CI): 0.63–0.82; p < 0.001). All-cause mortality was significantly lower in DOACs group compared with warfarin group (RR: 0.82; 95% CI: 0.70–0.96; p = 0.012). Compared to warfarin, DOACs were not associated with reductions in major bleeding (RR: 0.85, 95% CI 0.69–1.04; p = 0.108) or gastrointestinal bleeding risk (RR: 1.08, 95% CI 0.76–1.53; p = 0.678) but a 43% reduction of intracranial bleeding (RR: 0.47, IC 95% 0.36–0.60; p < 0.001) was observed. Our meta-analysis demonstrates that DOACs are effective and safe with statistical superiority when compared with warfarin in octogenarians with AF. |
format | Online Article Text |
id | pubmed-8618042 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86180422021-11-27 Direct Oral Anticoagulants versus Warfarin in Octogenarians with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis Bonanad, Clara García-Blas, Sergio Torres Llergo, Javier Fernández-Olmo, Rosa Díez-Villanueva, Pablo Ariza-Solé, Albert Martínez-Sellés, Manuel Raposeiras, Sergio Ayesta, Ana Bertomeu-González, Vicente Tarazona Santabalbina, Francisco Facila, Lorenzo Vivas, David Gabaldón-Pérez, Ana Bodi, Vicente Nuñez, Julio Cordero, Alberto J Clin Med Review Direct oral anticoagulants (DOACs) have been demonstrated to be more effective and safer than vitamin-K antagonist (VKA) for stroke prevention in patients with nonvalvular atrial fibrillation (AF). This meta-analysis aims to assess the effect of DOACS vs. VKA in patients ≥ 80 and AF. Primary endpoints were stroke or systemic embolism and all-cause death. Secondary endpoints included major bleeding, intracranial bleeding, and gastrointestinal bleeding. A random-effects model was selected due to significant heterogeneity. A total of 147,067 patients from 16 studies were included, 71,913 (48.90%) treated with DOACs and 75,154 with VKA (51.10%). The stroke rate was significantly lower in DOACs group compared with warfarin group (Relative risk (RR): 0.72; 95% confidence interval (CI): 0.63–0.82; p < 0.001). All-cause mortality was significantly lower in DOACs group compared with warfarin group (RR: 0.82; 95% CI: 0.70–0.96; p = 0.012). Compared to warfarin, DOACs were not associated with reductions in major bleeding (RR: 0.85, 95% CI 0.69–1.04; p = 0.108) or gastrointestinal bleeding risk (RR: 1.08, 95% CI 0.76–1.53; p = 0.678) but a 43% reduction of intracranial bleeding (RR: 0.47, IC 95% 0.36–0.60; p < 0.001) was observed. Our meta-analysis demonstrates that DOACs are effective and safe with statistical superiority when compared with warfarin in octogenarians with AF. MDPI 2021-11-12 /pmc/articles/PMC8618042/ /pubmed/34830548 http://dx.doi.org/10.3390/jcm10225268 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Bonanad, Clara García-Blas, Sergio Torres Llergo, Javier Fernández-Olmo, Rosa Díez-Villanueva, Pablo Ariza-Solé, Albert Martínez-Sellés, Manuel Raposeiras, Sergio Ayesta, Ana Bertomeu-González, Vicente Tarazona Santabalbina, Francisco Facila, Lorenzo Vivas, David Gabaldón-Pérez, Ana Bodi, Vicente Nuñez, Julio Cordero, Alberto Direct Oral Anticoagulants versus Warfarin in Octogenarians with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis |
title | Direct Oral Anticoagulants versus Warfarin in Octogenarians with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis |
title_full | Direct Oral Anticoagulants versus Warfarin in Octogenarians with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis |
title_fullStr | Direct Oral Anticoagulants versus Warfarin in Octogenarians with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Direct Oral Anticoagulants versus Warfarin in Octogenarians with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis |
title_short | Direct Oral Anticoagulants versus Warfarin in Octogenarians with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis |
title_sort | direct oral anticoagulants versus warfarin in octogenarians with nonvalvular atrial fibrillation: a systematic review and meta-analysis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618042/ https://www.ncbi.nlm.nih.gov/pubmed/34830548 http://dx.doi.org/10.3390/jcm10225268 |
work_keys_str_mv | AT bonanadclara directoralanticoagulantsversuswarfarininoctogenarianswithnonvalvularatrialfibrillationasystematicreviewandmetaanalysis AT garciablassergio directoralanticoagulantsversuswarfarininoctogenarianswithnonvalvularatrialfibrillationasystematicreviewandmetaanalysis AT torresllergojavier directoralanticoagulantsversuswarfarininoctogenarianswithnonvalvularatrialfibrillationasystematicreviewandmetaanalysis AT fernandezolmorosa directoralanticoagulantsversuswarfarininoctogenarianswithnonvalvularatrialfibrillationasystematicreviewandmetaanalysis AT diezvillanuevapablo directoralanticoagulantsversuswarfarininoctogenarianswithnonvalvularatrialfibrillationasystematicreviewandmetaanalysis AT arizasolealbert directoralanticoagulantsversuswarfarininoctogenarianswithnonvalvularatrialfibrillationasystematicreviewandmetaanalysis AT martinezsellesmanuel directoralanticoagulantsversuswarfarininoctogenarianswithnonvalvularatrialfibrillationasystematicreviewandmetaanalysis AT raposeirassergio directoralanticoagulantsversuswarfarininoctogenarianswithnonvalvularatrialfibrillationasystematicreviewandmetaanalysis AT ayestaana directoralanticoagulantsversuswarfarininoctogenarianswithnonvalvularatrialfibrillationasystematicreviewandmetaanalysis AT bertomeugonzalezvicente directoralanticoagulantsversuswarfarininoctogenarianswithnonvalvularatrialfibrillationasystematicreviewandmetaanalysis AT tarazonasantabalbinafrancisco directoralanticoagulantsversuswarfarininoctogenarianswithnonvalvularatrialfibrillationasystematicreviewandmetaanalysis AT facilalorenzo directoralanticoagulantsversuswarfarininoctogenarianswithnonvalvularatrialfibrillationasystematicreviewandmetaanalysis AT vivasdavid directoralanticoagulantsversuswarfarininoctogenarianswithnonvalvularatrialfibrillationasystematicreviewandmetaanalysis AT gabaldonperezana directoralanticoagulantsversuswarfarininoctogenarianswithnonvalvularatrialfibrillationasystematicreviewandmetaanalysis AT bodivicente directoralanticoagulantsversuswarfarininoctogenarianswithnonvalvularatrialfibrillationasystematicreviewandmetaanalysis AT nunezjulio directoralanticoagulantsversuswarfarininoctogenarianswithnonvalvularatrialfibrillationasystematicreviewandmetaanalysis AT corderoalberto directoralanticoagulantsversuswarfarininoctogenarianswithnonvalvularatrialfibrillationasystematicreviewandmetaanalysis |